Karyopharm Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. HUBS

Go back to Karyopharm Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress

Karyopharm Therapeutics (KPTI) Tops Q1 EPS by 7c; Offers FY23 Revenue Guidance

May 4, 2023 8:21 AM EDT

Karyopharm Therapeutics (NASDAQ: KPTI) reported Q1 EPS of ($0.30), $0.07 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $38.7 million versus the consensus estimate of $36.3 million.

GUIDANCE:

Karyopharm Therapeutics sees FY2023 revenue of $145-160 million, versus the consensus of... More